Ph.D., biostatistics, Harvard University; B.A., biology, Cornell University
Summary of Experience
Dr. Signorovitch advises pharmaceutical and medical device companies, drawing on his research on the value of health care products. He has broad experience with the development and implementation of health economics and outcomes research strategies in a number of therapeutic areas and disease states, including cardiovascular medicine, diabetes, oncology, immunology, and infectious diseases. Dr. Signorovitch specializes in the development and application of new research methods for health data, including electronic medical records, chart reviews, surveys, registries, and administrative claims. He has designed and analyzed clinical trials, performed benefit-risk analyses, developed health economic models, validated quality-of-life instruments, investigated the impacts of formulary policy changes, built predictive models for health risks, and led the creation of software to support medical decision making. Dr. Signorovitch’s research has been published in peer-reviewed journals and presented at clinical and economic research conferences, as well as to health care payers to inform formulary decisions. Prior to joining Analysis Group, Dr. Signorovitch was a research fellow at the Harvard-MIT Division of Health Sciences and Technology.